Tuesday May 22 | Investopedia
Agilent Pays A Hefty Price For A Fixer-Upper Diagnostics Company
It was just a day ago that I wrote, in reference to Agilent 's probable M&A strategy, "I would be surprised if the company targeted sequencing or diagnostics." Well, color me surprised, as Agilent announced on the morning of May 17 that it will be acquiring Danish oncology diagnostic company Dako for $2.2 billion in cash.
Zacks Reiterates "Neutral" Rating on Hologic
's stock had its "neutral" rating restated by Zacks in a research report issued to clients and investors on Thursday.
Stock Insights: Hologic, Select Comfort, Frontier Communications, Fossil May 8th
Hologic Inc. : After Hologic agreed to acquire Gen-Probe , Argus believes that the deal will position Hologic as the premiere women's health-focused company.
Hologic features minimally invasive technologies at ACOG annual clinical meeting
Hologic, Inc. , a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, is featuring minimally invasive technologies in surgical, diagnostic and skeletal health at The American College of Obstetricians and Gynecologists annual ... (more)
Hologic Delivers on Its Promise to Provide Innovative, Minimally...
Hologic Delivers on Its Promise to Provide Innovative, Minimally Invasive Technologies for Gynecologists and Obstetricians at the ACOG Annual Clinical Meeting BEDFORD, Mass., May 7, 2012 /PRNewswire/ -- Hologic, Inc.
Hologic Acquires Gen-Probe For $82.75 Per Share
Hologic announced its acquisition of Gen-Probe in a cash deal valued at $82.75 a share, which represents a 20% premium over the company's Friday close.The company expects the deal to add $0.20 per share to adjusted EPS in its first year after the closing of the deal.Hologic expects to fund the deal through cash, and added term loans.
Hologic's Poor Price Action Doesn't Thwart Call Players
Most popular has been the May 17 strike, where more than 2,800 of these calls have crossed -- the majority of them at the ask price, indicating they were purchased.